Dorien Groenendaal, Gregory Strabach, Alberto Garcia-Hernandez, Takeshi Kadokura, Marten Heeringa, Roelof Mol, Charlotte Eltink and Hartmut Onkels The pharmacokinetics of darexaban are not affected to a clinically relevant degree by rifampicin, a strong inducer of P-glycoprotein and CYP3A4 British Journal of Clinical Pharmacology 75
Article first published online: 10 JAN 2013 | DOI: 10.1111/j.1365-2125.2012.04346.x
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.